UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

POS0877 THE EFFECT OF PLATELET INHIBITORS ON DIGITAL ULCERS IN SYSTEMIC SCLEROSIS - A DERIVATION AND VALIDATION EUSTAR STUDY

Annals of the rheumatic diseases, 2021-06, Vol.80 (Suppl 1), p.694-695

2021

Volltextzugriff (PDF)

Clinical significance of the anti-Nucleolar Organizer Region 90 antibodies (NOR90) in systemic sclerosis: Analysis of the European Scleroderma Trials and Research (EUSTAR) cohort and a systematic literature review

European journal of internal medicine, 2024-07, Vol.125, p.104-110

2024

Volltextzugriff (PDF)

MODELING OF HUMAN SPINAL COLUMN AND SIMULATION OF SPINAL DEFORMITIES

Mechanika (Kaunas, Lithuania : 1995), 2015-05, Vol.21 (3)

2015

Volltextzugriff (PDF)

AB0411 CHALLENGES IN THE MANAGEMENT OF MIXED CONNECTIVE TISSUE DISEASE: A RETROSPECTIVE ANALYSIS OF THE MCTD COHORT IN A TERTIARY REFERRAL CENTRE

Annals of the rheumatic diseases, 2021-06, Vol.80 (Suppl 1), p.1233-1234

2021

Volltextzugriff (PDF)

POS0892 IDENTIFICATION OF DEFINED MICROANGIOPATHIC CHANGES IN NAILFOLD CAPILLAROSCOPY IMAGES OF PATIENTS WITH SYSTEMIC SCLEROSIS USING A VISION TRANSFORMER MODEL – A MONOCENTRIC IMPLEMENTATION AND VALIDATION COHORT STUDY

Annals of the rheumatic diseases, 2022-06, Vol.81 (Suppl 1), p.743-743

2022

Volltextzugriff (PDF)

FRI0240 HOSPITAL ANXIETY AND DEPRESSION SCALE AND SENSE OF COHERENCE 13-ITEM SCALE IN A SWISS COHORT OF SYSTEMIC SCLEROSIS PATIENTS: VALIDITY, RELIABILITY AND SENSITIVITY TO CHANGE

Annals of the rheumatic diseases, 2020-06, Vol.79 (Suppl 1), p.704-704

2020

Volltextzugriff (PDF)

OP0003 DOES IMMUNOSUPPRESSIVE THERAPY IMPROVE GASTROINTESTINAL SYMPTOMS IN PATIENTS WITH SYSTEMIC SCLEROSIS?

Annals of the rheumatic diseases, 2022-06, Vol.81 (Suppl 1), p.2-3

2022

Volltextzugriff (PDF)

POS0878 ASSOCIATION OF A LOWER BODY-MASS INDEX WITH THE PRESENCE OF ILD IN SSc PATIENTS – A DERIVATION PREDICTION STUDY USING DECISION TREE-BASED ALGORITHMS

Annals of the rheumatic diseases, 2022-06, Vol.81 (Suppl 1), p.734-735

2022

Volltextzugriff (PDF)

POS1273 CHARACTERISTICS AND DISEASE COURSE OF UNTREATED PATIENTS WITH INTERSTITIAL LUNG DISEASE ASSOCIATED WITH SYSTEMIC SCLEROSIS IN A REAL-LIFE TWO-CENTER COHORT

Annals of the rheumatic diseases, 2023-06, Vol.82 (Suppl 1), p.981-981

2023

Volltextzugriff (PDF)

FRI0267 CLINICAL CORRELATES AND RELEVANCE OF UCLA GIT 2.0 FOR ESOPHAGITIS AND INDICATION FOR ESOPHAGOGASTRODUODENOSCOPY IN REAL-LIFE PATIENTS WITH SYSTEMIC SCLEROSIS

Annals of the rheumatic diseases, 2020-06, Vol.79 (Suppl 1), p.718-718

2020

Volltextzugriff (PDF)

POS0432 DRIVERS OF DISEASE BURDEN IN PATIENTS WITH SYSTEMIC SCLEROSIS ACROSS CLINICAL AND DEMOGRAPHIC SUBGROUPS REVEALED BY THE EULAR SYSTEMIC SCLEROSIS IMPACT OF DISEASE (ScleroID) QUESTIONNAIRE

Annals of the rheumatic diseases, 2024-06, Vol.83 (Suppl 1), p.342-343

2024

Volltextzugriff (PDF)

POS0388 DEVELOPING A SCREENING TOOL FOR THE DETECTION OF INTERSTITIAL LUNG DISEASE IN SYSTEMIC SCLEROSIS: THE ILD-RISC RISK SCORE

Annals of the rheumatic diseases, 2022-06, Vol.81 (Suppl 1), p.449-450

2022

Volltextzugriff (PDF)

POS0880 CHARACTERISTICS AND DISEASE COURSE OF UNTREATED PATIENTS WITH INTERSTITIAL LUNG DISEASE ASSOCIATED WITH SYSTEMIC SCLEROSIS

Annals of the rheumatic diseases, 2022-06, Vol.81 (Suppl 1), p.735-736

2022

Volltextzugriff (PDF)

POS1255 CLINICAL SIGNIFICANCE OF THE ANTI-NUCLEOLAR ORGANIZER REGION 90 ANTIBODIES (NOR90) IN SYSTEMIC SCLEROSIS: A EUROPEAN SCLERODERMA TRIALS AND RESEARCH (EUSTAR) ANALYSIS

Annals of the rheumatic diseases, 2023-06, Vol.82 (Suppl 1), p.969-970

2023

Volltextzugriff (PDF)

POS0342 PERFORMANCE OF THE EULAR SYSTEMIC SCLEROSIS IMPACT OF DISEASE (SCLEROID) QUESTIONNAIRE AS A PATIENT REPORTED OUTCOME MEASURE FOR PATIENTS WITH DIFFUSE SYSTEMIC SCLEROSIS

Annals of the rheumatic diseases, 2023-06, Vol.82 (Suppl 1), p.418-419

2023

Volltextzugriff (PDF)

AB0823 A BAYESIAN APPROACH TO DETERMINE THE ROLE OF ORAL ANTICOAGULANTS FOR THE OCCURRENCE OF DIGITAL ULCERS IN SYSTEMIC SCLEROSIS – A EUSTAR OBSERVATIONAL STUDY

Annals of the rheumatic diseases, 2023-06, Vol.82 (Suppl 1), p.1624-1625

2023

Volltextzugriff (PDF)

The Hospital Anxiety and Depression Scale in patients with systemic sclerosis: a psychometric and factor analysis in a monocentric cohort

Clinical and experimental rheumatology, 2021-01

2021

Volltextzugriff (PDF)

Detailed Analysis of Apoptosis and Delayed Luminescence of Human Leukemia Jurkat T Cells after Proton Irradiation and Treatments with Oxidant Agents and Flavonoids

Oxidative medicine and cellular longevity, 2012-01, Vol.2012 (2012), p.1-14

2012

Volltextzugriff (PDF)

SAT0681 Risk of active tuberculosis in patients with inflammatory arthritis receiving tnf-inhibitors

Annals of the rheumatic diseases, 2017-06, Vol.76 (Suppl 2), p.1032

2017

Volltextzugriff (PDF)

Multimodal Emotion Recognition System based on X-Vector Embeddings and Convolutional Neural Networks

IEEE International Conference on Communications (2003), 2024, p.1-6

2024

Volltextzugriff (PDF)

COVID-19 in a patient with systemic sclerosis treated with tocilizumab for SSc-ILD

Annals of the rheumatic diseases, 2020-05, Vol.79 (5), p.668-669

2020

Volltextzugriff (PDF)

Therapeutic management of fibrosis in systemic sclerosis patients - an analysis from the Swiss EUSTAR cohort

Swiss medical weekly, 2024-02, Vol.154 (2), p.3630

2024

Volltextzugriff (PDF)

The enigma of mixed connective tissue disease—challenges in routine care

Clinical rheumatology, 2022-11, Vol.41 (11), p.3503-3511

2022

Volltextzugriff (PDF)

Performance of the UCLA Scleroderma Clinical Trials Consortium Gastrointestinal Tract 2.0 instrument as a clinical decision aid in the routine clinical care of patients with systemic sclerosis

Arthritis research & therapy, 2021-04, Vol.23 (1), p.125-125, Article 125

2021

Volltextzugriff (PDF)

The incremental value of the contribution of a biostatistician to the reporting quality in health research-A retrospective, single center, observational cohort study

PloS one, 2022-03, Vol.17 (3), p.e0264819-e0264819

2022

Volltextzugriff (PDF)

1 – 25 von 44

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(36)
Mit Volltextzugriff
(17)

Publikationsform

Sprache

Englisch
(43)
Rumänisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(19)
Life Sciences & Biomedicine
(17)
Systemic Sclerosis
(16)
Rheumatology
(14)
Scleroderma
(13)
Patients
(12)
Humans
(10)
Clinical Trials
(8)
Lung Diseases
(6)
Questionnaires
(5)
Scleroderma, Systemic - Complications
(5)
Dyspnea
(4)
Fibrosis
(4)
Ulcers
(4)
Apoptosis - Drug Effects
(3)
Arthritis
(3)
Cell Survival - Drug Effects
(3)
Clinical Outcomes
(3)
Cohort Analysis
(3)
Connective Tissue Diseases
(3)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

POS0877 THE EFFECT OF PLATELET INHIBITORS ON DIGITAL ULCERS IN SYSTEMIC SCLEROSIS - A DERIVATION AND VALIDATION EUSTAR STUDY

Clinical significance of the anti-Nucleolar Organizer Region 90 antibodies (NOR90) in systemic sclerosis: Analysis of the European Scleroderma Trials and Research (EUSTAR) cohort and a systematic literature review

MODELING OF HUMAN SPINAL COLUMN AND SIMULATION OF SPINAL DEFORMITIES

AB0411 CHALLENGES IN THE MANAGEMENT OF MIXED CONNECTIVE TISSUE DISEASE: A RETROSPECTIVE ANALYSIS OF THE MCTD COHORT IN A TERTIARY REFERRAL CENTRE

POS0892 IDENTIFICATION OF DEFINED MICROANGIOPATHIC CHANGES IN NAILFOLD CAPILLAROSCOPY IMAGES OF PATIENTS WITH SYSTEMIC SCLEROSIS USING A VISION TRANSFORMER MODEL – A MONOCENTRIC IMPLEMENTATION AND VALIDATION COHORT STUDY

FRI0240 HOSPITAL ANXIETY AND DEPRESSION SCALE AND SENSE OF COHERENCE 13-ITEM SCALE IN A SWISS COHORT OF SYSTEMIC SCLEROSIS PATIENTS: VALIDITY, RELIABILITY AND SENSITIVITY TO CHANGE

OP0003 DOES IMMUNOSUPPRESSIVE THERAPY IMPROVE GASTROINTESTINAL SYMPTOMS IN PATIENTS WITH SYSTEMIC SCLEROSIS?

POS0878 ASSOCIATION OF A LOWER BODY-MASS INDEX WITH THE PRESENCE OF ILD IN SSc PATIENTS – A DERIVATION PREDICTION STUDY USING DECISION TREE-BASED ALGORITHMS

POS1273 CHARACTERISTICS AND DISEASE COURSE OF UNTREATED PATIENTS WITH INTERSTITIAL LUNG DISEASE ASSOCIATED WITH SYSTEMIC SCLEROSIS IN A REAL-LIFE TWO-CENTER COHORT

FRI0267 CLINICAL CORRELATES AND RELEVANCE OF UCLA GIT 2.0 FOR ESOPHAGITIS AND INDICATION FOR ESOPHAGOGASTRODUODENOSCOPY IN REAL-LIFE PATIENTS WITH SYSTEMIC SCLEROSIS

POS0432 DRIVERS OF DISEASE BURDEN IN PATIENTS WITH SYSTEMIC SCLEROSIS ACROSS CLINICAL AND DEMOGRAPHIC SUBGROUPS REVEALED BY THE EULAR SYSTEMIC SCLEROSIS IMPACT OF DISEASE (ScleroID) QUESTIONNAIRE

POS0388 DEVELOPING A SCREENING TOOL FOR THE DETECTION OF INTERSTITIAL LUNG DISEASE IN SYSTEMIC SCLEROSIS: THE ILD-RISC RISK SCORE

POS0880 CHARACTERISTICS AND DISEASE COURSE OF UNTREATED PATIENTS WITH INTERSTITIAL LUNG DISEASE ASSOCIATED WITH SYSTEMIC SCLEROSIS

POS1255 CLINICAL SIGNIFICANCE OF THE ANTI-NUCLEOLAR ORGANIZER REGION 90 ANTIBODIES (NOR90) IN SYSTEMIC SCLEROSIS: A EUROPEAN SCLERODERMA TRIALS AND RESEARCH (EUSTAR) ANALYSIS

POS0342 PERFORMANCE OF THE EULAR SYSTEMIC SCLEROSIS IMPACT OF DISEASE (SCLEROID) QUESTIONNAIRE AS A PATIENT REPORTED OUTCOME MEASURE FOR PATIENTS WITH DIFFUSE SYSTEMIC SCLEROSIS

AB0823 A BAYESIAN APPROACH TO DETERMINE THE ROLE OF ORAL ANTICOAGULANTS FOR THE OCCURRENCE OF DIGITAL ULCERS IN SYSTEMIC SCLEROSIS – A EUSTAR OBSERVATIONAL STUDY

The Hospital Anxiety and Depression Scale in patients with systemic sclerosis: a psychometric and factor analysis in a monocentric cohort

Detailed Analysis of Apoptosis and Delayed Luminescence of Human Leukemia Jurkat T Cells after Proton Irradiation and Treatments with Oxidant Agents and Flavonoids

SAT0681 Risk of active tuberculosis in patients with inflammatory arthritis receiving tnf-inhibitors

Multimodal Emotion Recognition System based on X-Vector Embeddings and Convolutional Neural Networks

COVID-19 in a patient with systemic sclerosis treated with tocilizumab for SSc-ILD

Therapeutic management of fibrosis in systemic sclerosis patients - an analysis from the Swiss EUSTAR cohort

The enigma of mixed connective tissue disease—challenges in routine care

Performance of the UCLA Scleroderma Clinical Trials Consortium Gastrointestinal Tract 2.0 instrument as a clinical decision aid in the routine clinical care of patients with systemic sclerosis

The incremental value of the contribution of a biostatistician to the reporting quality in health research-A retrospective, single center, observational cohort study

Suchergebnisse filtern